In older patients with AF and frailty, switching from VKA to NOAC therapy increased a composite of major or CRNM bleeding at 12 mo

Andrew Dunn

doi:10.7326/J24-0024

In older patients with AF and frailty, switching from VKA to NOAC therapy increased a composite of major or CRNM bleeding at 12 mo

Research output: Contribution to journal › Comment/debate

Abstract

SOURCE CITATION: Joosten LP, van Doorn S, van de Ven PM, et al. Safety of switching from a vitamin K antagonist to a non-vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation: results of the FRAIL-AF randomized controlled trial. Circulation. 2024;149:279-289. 37634130.

Original language	English
Pages (from-to)	JC57
Journal	Annals of Internal Medicine
Volume	177
Issue number	5
DOIs	https://doi.org/10.7326/J24-0024
State	Published - 1 May 2024

Access to Document

10.7326/J24-0024

Cite this

@article{306ce0a7ca434426b9b2821315c8fc66,

title = "In older patients with AF and frailty, switching from VKA to NOAC therapy increased a composite of major or CRNM bleeding at 12 mo",

abstract = "SOURCE CITATION: Joosten LP, van Doorn S, van de Ven PM, et al. Safety of switching from a vitamin K antagonist to a non-vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation: results of the FRAIL-AF randomized controlled trial. Circulation. 2024;149:279-289. 37634130.",

author = "Andrew Dunn",

year = "2024",

month = may,

day = "1",

doi = "10.7326/J24-0024",

language = "English",

volume = "177",

pages = "JC57",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "5",

}

TY - JOUR

T1 - In older patients with AF and frailty, switching from VKA to NOAC therapy increased a composite of major or CRNM bleeding at 12 mo

AU - Dunn, Andrew

PY - 2024/5/1

Y1 - 2024/5/1

N2 - SOURCE CITATION: Joosten LP, van Doorn S, van de Ven PM, et al. Safety of switching from a vitamin K antagonist to a non-vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation: results of the FRAIL-AF randomized controlled trial. Circulation. 2024;149:279-289. 37634130.

AB - SOURCE CITATION: Joosten LP, van Doorn S, van de Ven PM, et al. Safety of switching from a vitamin K antagonist to a non-vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation: results of the FRAIL-AF randomized controlled trial. Circulation. 2024;149:279-289. 37634130.

UR - http://www.scopus.com/inward/record.url?scp=85194013185&partnerID=8YFLogxK

U2 - 10.7326/J24-0024

DO - 10.7326/J24-0024

M3 - Comment/debate

C2 - 38710082

AN - SCOPUS:85194013185

SN - 0003-4819

VL - 177

SP - JC57

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

IS - 5

ER -

In older patients with AF and frailty, switching from VKA to NOAC therapy increased a composite of major or CRNM bleeding at 12 mo

Abstract

Access to Document

Fingerprint

Cite this